Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Aug 11, 2026, after the close
10-Q filed Aug 11, 2026, 42 days after period end · 0001493152-26-037147
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$3.95M | -$3.75M | -$2.61M | -$1.63M |
| EPS Diluted | -$0.27 | -$0.28 | -$0.20 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d after period end
+8.8% from the close of Aug 11, 2026 to the close of Aug 12, 2026, the first after the release.